美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

CAR-T

1,382.59

+5.930.43%

涨家数：3

跌家数：- -

平家数：- -

市盈率：- -

高：1,396.81

开：1,376.83

低：1,376.83

收：1,376.66

数据加载中...

总览新闻资讯

美股抗疫概念股集体上涨，Moderna涨近16%

每日经济新闻

蓝鸟生物盘中异动股价大涨5.24%

【欧股“十一罗汉”｜诺和诺德收涨约2.5%，阿斯麦涨超1.8%，雀巢则跌超1.8%】周三，阿斯麦控股荷兰阿姆斯特丹股价收涨1.85%，报672.70欧元。诺和诺德哥本哈根股价收涨2.48%，报631.50。德国思爱普Sap收涨2.22%，欧莱雅涨1.79%，诺华制药涨0.62%。阿斯利康、罗氏制药、LVMH集团、赛诺菲则收跌0.02%-0.46%，葛兰素史克跌1.72%，雀巢跌1.83%。

吉利德科学公司预留 2 亿美元解决艾滋病药物调查问题

蓝鸟生物盘中异动早盘股价大跌5.82%

诺华(NVS.US)放射性癌症疗法1类新药在中国获批临床

蓝鸟生物盘中异动早盘股价大涨5.26%报4.00美元

吉利德的中年困境：抱住CAR-T的浮木

诺华(NVS.US)BTK抑制剂“瑞米布替尼”率先在华申报上市

百济神州回应原大中华区CFO离职：将尽快启动其继任者的招聘

百济神州大中华区CFO黄智已经离职

【欧股“十一罗汉”｜阿斯麦收跌2.2%，Hims减肥药业务前景提振诺和诺德收涨约2.8%】周二，阿斯麦控股荷兰阿姆斯特丹股价收跌2.20%，报697.80欧元。诺和诺德哥本哈根股价收涨2.78%，报657.00，美国平价减肥药供应商Hims & Hers Health停售某些减肥药。诺华制药与葛兰素史克至多涨2.35%，雀巢和阿斯利康至多涨1.41%，赛诺菲和罗氏制药至多涨行0.7%，欧莱雅收平，德国思爱普Sap则收跌0.69%，LVMH集团跌1.14%。

诺华制药盘中异动股价大涨3.00%

Biotech众生相：蓝鸟生物以最高1亿美元被收购

国际金融报

困境Biotech这就不收购了？

吉利德(GILD.US)突破性长效HIV疗法在欧洲获得加速审评

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/BK4578/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4578"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","market":"US","secType":"PLATE","nameCN":"CAR-T","latestPrice":1382.588,"timestamp":1741208399999,"preClose":1376.6566,"halted":0,"volume":18213174,"delay":0,"changeRate":0.004309,"change":5.931396,"pbRate":5.765336,"amount":2063456275.663362,"amplitude":0.014515,"prevYearClose":1164.883,"fiveDayClose":1330.3182,"twentyDayClose":1252.4534,"turnoverRate":0.005809,"marketCap":364774630820,"floatMarketCap":354170504940,"peRate":30.124118},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4578\",,,,,undefined,":{"symbol":"BK4578","high":1396.8141,"amplitude":0.014515,"preClose":1376.6566,"low":1376.8324,"pbRate":"5.765336","latestPrice":1382.588,"volume":18213174,"delay":0,"open":1376.8324,"prevYearClose":1164.883,"prevWeekClose":1356.2184,"prevMonthClose":1356.2184,"prevQuarterClose":1164.883,"fiveDayClose":1330.3182,"twentyDayClose":1252.4534,"sixtyDayClose":1190.7347,"secType":"PLATE","market":"US","turnoverRate":0.005809,"peRate":30.124118,"marketCap":364774630820,"floatMarketCap":354170504940,"timestamp":1741208399999,"nameCN":"CAR-T"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4578\",,,,undefined,":{"bkCode":"BK4578","up":3,"down":0,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4578\",pageSize:16,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517920878","title":"美股抗疫概念股集体上涨，Moderna涨近16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517920878","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517920878?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 05:54","pubTimestamp":1741211660,"startTime":"0","endTime":"0","summary":"每经AI快讯，周三（3月5日），美股抗疫概念股集体上涨，Moderna涨近16%，吉利德科学涨0.61%，诺瓦瓦克斯医药涨超2%，BioNTech涨逾4%，阿斯利康涨0.92%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503063337642255.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063337642255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4550","BK4547","IE0002270589.USD","LU0234570918.USD","LU2089984988.USD","BK4566","IE00BSNM7G36.USD","LU1066051498.USD","LU1839511570.USD","BK4588","GILD","IE00B19Z3B42.SGD","LU1430594728.SGD","BK4568","LU0889565916.HKD","LU1066053197.SGD","IE00B7SZLL34.SGD","LU1585245621.USD","BK4583","IE00BZ1G4Q59.USD","BK4139","IE00B19Z3581.USD","LU0058720904.USD","BK4532","LU2468319806.SGD","LU0289739699.SGD","BK4585","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0109394709.USD","LU0320765992.SGD","LU1571399168.USD","NVAX","LU2087621335.USD","BK4578"],"gpt_icon":0},{"id":"2517923427","title":"蓝鸟生物盘中异动 股价大涨5.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517923427","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517923427?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 03:22","pubTimestamp":1741202566,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时22分，蓝鸟生物股票出现波动，股价大幅拉升5.24%。截至发稿，该股报4.02美元/股，成交量18.2446万股，换手率1.87%，振幅4.97%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为2.06%。其相关个股中，Chimerix, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Tonix Pharmaceuticals Holding Corp.涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为960.68%、313.94%、307.90%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Marker Therapeutics, Inc.，振幅分别为82.59%、54.27%、50.73%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306032247963b1b53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306032247963b1b53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BLUE","BK4578","BK4556","BK4139"],"gpt_icon":0},{"id":"2517477049","title":"【欧股“十一罗汉”｜诺和诺德收涨约2.5%，阿斯麦涨超1.8%，雀巢则跌超1.8%】 周三，阿斯麦控股荷兰阿姆斯特丹股价收涨1.85%，报672.70欧元。诺和诺德哥本哈根股价收涨2.48%，报631.50。德国思爱普Sap收涨2.22%，欧莱雅涨1.79%，诺华制药涨0.62%。阿斯利康、罗氏制药、LVMH集团、赛诺菲则收跌0.02%-0.46%，葛兰素史克跌1.72%，雀巢跌1.83%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2517477049","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517477049?lang=zh_cn&edition=fundamental","pubTime":"2025-03-06 01:53","pubTimestamp":1741197233,"startTime":"0","endTime":"0","summary":"周三，阿斯麦控股荷兰阿姆斯特丹股价收涨1.85%，报672.70欧元。诺和诺德哥本哈根股价收涨2.48%，报631.50。德国思爱普Sap收涨2.22%，欧莱雅涨1.79%，诺华制药涨0.62%。阿斯利康、罗氏制药、LVMH集团、赛诺菲则收跌0.02%-0.46%，葛兰素史克跌1.72%，雀巢跌1.83%。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/06015348550800.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IE00BJJMRZ35.SGD","LU1734074674.USD","IE00BD6J9T35.USD","LU2417539215.USD","BK4578","LU0345774631.USD","IE00BJT1NW94.SGD","LU0823434583.USD","BK4585","BK4588","LU0211331839.USD","IE0009355771.USD","AZN","BK4212","LU0345774391.USD","LU0889565916.HKD","GSK","IE0002141913.USD","IE00B2B36J28.USD","LRLCY","LU1093756168.USD","03165","LU0823434740.USD","LU2456880835.USD","BK4147","IE00B4R5TH58.HKD","IE00BZ1G4Q59.USD","GSK.UK","IE00BFTCPJ56.SGD","BK4543","BK1574","NVS","LU0154236417.USD","IE0004445239.USD","LU1093756325.SGD","LU0097036916.USD","LU2462157665.USD","NSRGY","LU0109394709.USD","NVO","BK4532","LU0320765992.SGD","01477","BK4599","BK4007","IE00BKVL7J92.USD","BK1191","BK4568","LU2236285917.USD","ASML"],"gpt_icon":0},{"id":"2516965363","title":"吉利德科学公司预留 2 亿美元解决艾滋病药物调查问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2516965363","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516965363?lang=zh_cn&edition=fundamental","pubTime":"2025-03-04 00:18","pubTimestamp":1741018714,"startTime":"0","endTime":"0","summary":"路透社纽约3月3日 - 吉利德科学公司预留了2亿美元用于与联邦检察官可能达成的和解，以解决对该制药公司HIV药物促销扬声器计划的调查。吉利德公司说，它在2017年收到了传票，但在文件中没有提供有关调查的更多细节。曼哈顿联邦检察官办公室发言人拒绝发表评论。2024 年第四季度，吉利德公司的艾滋病药物销售额增长了 16% ，达到 54.5 亿美元，促使其股价飙升。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nL3S3PM18K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BSNM7G36.USD","LU0289739699.SGD","LU0109394709.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4583","BK4585","LU1066053197.SGD","LU0889565916.HKD","IE00B19Z3B42.SGD","LU2089984988.USD","LU2468319806.SGD","IE00BKVL7J92.USD","IE00B7SZLL34.SGD","IE0002270589.USD","BK4532","GILD","LU1839511570.USD","BK4139","LU1430594728.SGD","LU1571399168.USD","IE00B3T34201.USD","BK4566","BK4550","IE00B19Z3581.USD","BK4568","BK4578","LU1585245621.USD","LU0234570918.USD","LU2087621335.USD","LU1066051498.USD","BK4588","LU0320765992.SGD"],"gpt_icon":0},{"id":"2516632017","title":"蓝鸟生物盘中异动 早盘股价大跌5.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516632017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516632017?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 22:45","pubTimestamp":1741013150,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时45分，蓝鸟生物股票出现异动，股价快速下跌5.82%。截至发稿，该股报3.84美元/股，成交量4.1416万股，换手率0.43%，振幅4.90%。机构评级方面，在所有7家参与评级的机构中，14%的券商给予买入建议，86%的券商给予持有建议，无券商给予卖出建议。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.24%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224550989a1381&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303224550989a1381&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4556","BK4139","BK4578","BLUE"],"gpt_icon":0},{"id":"2516352896","title":"诺华(NVS.US)放射性癌症疗法1类新药在中国获批临床","url":"https://stock-news.laohu8.com/highlight/detail?id=2516352896","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516352896?lang=zh_cn&edition=fundamental","pubTime":"2025-03-03 21:26","pubTimestamp":1741008413,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，3月3日，中国国家药监局药品审评中心官网公示，诺华申报的1类新药[225Ac]Ac-PSMA-617注射液获批临床，拟开发治疗[177Lu]Lu-PSMA靶向治疗期间或之后进展的PSMA阳性转移性去势抵抗性前列腺癌。根据诺华官网管线资料可知，这是一款靶向PSMA的放射性配体疗法，已经在国际范围内进入2/3期临床研究阶段。本次是该产品首次在中国获批IND。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1257175.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","IE00B2B36J28.USD","LU0211331839.USD","IE0009355771.USD","BK4532","BK4588","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","BK4578","IE00BJT1NW94.SGD","NVS","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4007"],"gpt_icon":0},{"id":"2514937300","title":"蓝鸟生物盘中异动 早盘股价大涨5.26%报4.00美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514937300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514937300?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 23:19","pubTimestamp":1740755946,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时19分，蓝鸟生物股票出现波动，股价快速上涨5.26%。截至发稿，该股报4.00美元/股，成交量2.9904万股，换手率0.31%，振幅6.84%。蓝鸟生物股票所在的生物技术行业中，整体涨幅为0.22%。该信息摘要如下：毕竟蓝鸟生物曾是全球基因疗法领域的先驱，公司先后共推出三款“天价”产品，市值也一度逼近300亿美元。上市后，蓝鸟生物股价一路高歌猛进，市值一度逼近300亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231907963424dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231907963424dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4578","BK4556","BK4139","BLUE"],"gpt_icon":0},{"id":"2514037597","title":"吉利德的中年困境：抱住CAR-T的浮木","url":"https://stock-news.laohu8.com/highlight/detail?id=2514037597","media":"深蓝观","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514037597?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 18:48","pubTimestamp":1740739680,"startTime":"0","endTime":"0","summary":"2017年收购CAR-T巨头公司Kite是吉利德正式进入肿瘤治疗领域的标志。在拓展新领域之前，吉利德优势明显的依然是HIV和CAR-T领域，这也是吉利德布局的重点。在吉利德试水过的多个领域中，CAR-T俨然是目前最拿得出手的招牌。吉利德现在的当务之急是准备补充新一代CAR-T管线。吉利德于2020年3月收购的CD47单抗Magrolimab因安全性问题终止研发，49亿美元的投资打水漂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231011abe0f449&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228231011abe0f449&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BZ1G4Q59.USD","GILD","BK4139","BK4230","LU0109394709.USD","IE00B3T34201.USD","IE00B19Z3581.USD","LU0058720904.USD","LU1585245621.USD","LU0234570918.USD","BK4583","BK4568","IE00BSNM7G36.USD","IE0002270589.USD","BK4550","IE00B19Z3B42.SGD","BK4585","LU1571399168.USD","BK4566","LU2087621335.USD","LU1066051498.USD","LU2089984988.USD","LU0320765992.SGD","CAR","BK4578","LU1430594728.SGD","BK4532","LU1839511570.USD","IE00B7SZLL34.SGD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4588","LU0889565916.HKD","LU1066053197.SGD","LU2468319806.SGD","BK4022"],"gpt_icon":0},{"id":"2514384110","title":"诺华(NVS.US)BTK抑制剂“瑞米布替尼”率先在华申报上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2514384110","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514384110?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 13:47","pubTimestamp":1740635247,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，2月27日，CDE官网显示，诺华BTK抑制剂瑞米布替尼片率先在华申报上市。根据临床试验进展以及财报信息，推测此次申报的适应症为慢性自发性荨麻疹。CSU有效治疗选择有限，约60%患者在接受抗组胺药一线治疗后无法完全控制病情。2024年更新的长期数据表明，与安慰剂相比，remibrutinib在第12周所展现的显著的症状改善持续至第24周。按照第52周的评估结果，近半数患者完全没有瘙痒和荨麻疹症状。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255123.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"诺华(NVS.US)BTK抑制剂“瑞米布替尼”率先在华申报上市","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00B4R5TH58.HKD","BK4532","BK4588","IE00B2B36J28.USD","NVS","BK4578","IE0002141913.USD","LU0211331839.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","BK4007","IE00BJJMRZ35.SGD","BK4585"],"gpt_icon":0},{"id":"2514000941","title":"百济神州回应原大中华区CFO离职：将尽快启动其继任者的招聘","url":"https://stock-news.laohu8.com/highlight/detail?id=2514000941","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514000941?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 16:10","pubTimestamp":1740557408,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["06160","LU0211331839.USD","IE0009355771.USD","NVS","IE00B2B36J28.USD","BK4585","IE00BJJMRZ35.SGD","688235","ONC","BK1161","BK4007","IE00BJT1NW94.SGD","BK4588","BK4139","BK1583","BK4532","LU1969619763.USD","LU0307460666.USD","IE0002141913.USD","BK4578","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0588546209.SGD","LU2328871848.SGD","BK1588","BK0239","BK1500"],"gpt_icon":0},{"id":"2514009350","title":"百济神州大中华区CFO黄智已经离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2514009350","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514009350?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 15:01","pubTimestamp":1740553261,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["688235","IE00BJJMRZ35.SGD","LU0588546209.SGD","BK4578","IE00BJT1NW94.SGD","BK4585","BK4588","LU0211331839.USD","IE0009355771.USD","IE0002141913.USD","IE00B2B36J28.USD","IE00B4R5TH58.HKD","ONC","BK1161","IE00BFTCPJ56.SGD","06160","NVS","BK1588","LU2328871848.SGD","BK4532","BK1500","LU0307460666.USD","LU1969619763.USD","BK4007","BK0239","BK4139","BK1583"],"gpt_icon":0},{"id":"2514950017","title":"【欧股“十一罗汉”｜阿斯麦收跌2.2%，Hims减肥药业务前景提振诺和诺德收涨约2.8%】 周二，阿斯麦控股荷兰阿姆斯特丹股价收跌2.20%，报697.80欧元。诺和诺德哥本哈根股价收涨2.78%，报657.00，美国平价减肥药供应商Hims & Hers Health停售某些减肥药。诺华制药与葛兰素史克至多涨2.35%，雀巢和阿斯利康至多涨1.41%，赛诺菲和罗氏制药至多涨行0.7%，欧莱雅收平，德国思爱普Sap则收跌0.69%，LVMH集团跌1.14%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514950017","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514950017?lang=zh_cn&edition=fundamental","pubTime":"2025-02-26 01:54","pubTimestamp":1740506070,"startTime":"0","endTime":"0","summary":"周二，阿斯麦控股荷兰阿姆斯特丹股价收跌2.20%，报697.80欧元。诺和诺德哥本哈根股价收涨2.78%，报657.00，美国平价减肥药供应商Hims & Hers Health停售某些减肥药。诺华制药与葛兰素史克至多涨2.35%，雀巢和阿斯利康至多涨1.41%，赛诺菲和罗氏制药至多涨行0.7%，欧莱雅收平，德国思爱普Sap则收跌0.69%，LVMH集团跌1.14%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/26015448386051.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["01477","BK4212","LU1829250122.USD","BK4183","LU1093756325.SGD","LU0823434583.USD","LU2063271972.USD","BK4532","LU2456880835.USD","AZN","IE00BD6J9T35.USD","BK4599","BK1574","BK4007","LU0211331839.USD","IE0002141913.USD","BK4543","IE00B4R5TH58.HKD","LRLCY","NSRGY","LU2417539215.USD","LU0154236417.USD","IE00BZ1G4Q59.USD","LU0889565916.HKD","03165","LU2236285917.USD","BK4578","BK1191","IE00BJJMRZ35.SGD","LU1093756168.USD","IE0009355771.USD","LU2462157665.USD","NVS","BK4585","BK4147","GSK","IE00BJT1NW94.SGD","BK4568","IE00BKVL7J92.USD","IE00BFTCPJ56.SGD","LU0097036916.USD","LU0109394709.USD","IE00B2B36J28.USD","LU1734074674.USD","LU0823434740.USD","IE0004445239.USD","GSK.UK","LU0320765992.SGD","ASML","NVO"],"gpt_icon":0},{"id":"2514681016","title":"诺华制药盘中异动 股价大涨3.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514681016","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514681016?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 23:32","pubTimestamp":1740497521,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时32分，诺华制药股票出现异动，股价大幅上涨3.00%。截至发稿，该股报112.50美元/股，成交量41.393万股，换手率0.02%，振幅0.91%。诺华制药股票所在的制药行业中，整体涨幅为1.82%。其相关个股中，Scilex Holding Company C/Wts 10/11/2027 、Cyclo Therapeutics Inc C/Wts 11/12/2025、Bausch Health Companies Inc.涨幅较大，Redhill Biopharma Ltd、Petros Pharmaceuticals, Inc.、苏轩堂较为活跃，换手率分别为161.08%、155.31%、65.59%，振幅较大的相关个股有Redhill Biopharma Ltd、Biofrontera Inc C/Wts 27/10/2026 、Sunshine Biopharma Inc C/Wts ，振幅分别为50.39%、43.55%、31.25%。诺华制药公司简介：诺华开发和生产创新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233201abdc8db2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225233201abdc8db2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","IE00B4R5TH58.HKD","IE0002141913.USD","BK4578","IE00BJT1NW94.SGD","LU0211331839.USD","IE00BJJMRZ35.SGD","BK4585","BK4532","NVS","IE00BFTCPJ56.SGD","BK4588","IE00B2B36J28.USD","IE0009355771.USD"],"gpt_icon":0},{"id":"2514673780","title":"Biotech众生相：蓝鸟生物以最高1亿美元被收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2514673780","media":"国际金融报","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514673780?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 19:13","pubTimestamp":1740482032,"startTime":"0","endTime":"0","summary":"上市后，蓝鸟生物股价一路高歌猛进，市值一度逼近300亿美元。截至去年第三季度，蓝鸟生物去年实现营收4528.6万美元，亏损2.12亿美元。果不其然，蓝鸟生物在今年2月宣布“卖身”，但最高1亿美元的价格还是让市场为之震惊。两项合计，此次交易的最高潜在金额约为1亿美元。Biotech众生相在被收购前，蓝鸟生物也曾采取过一系列措施“自救”。其中普方生物的交易金额创下新高，总金额高达130亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225191403962fc16a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225191403962fc16a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SCD","BK4578","BK4556","BK4139","BMS","BLUE"],"gpt_icon":0},{"id":"2514698690","title":"困境Biotech这就不收购了？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514698690","media":"谈思生物","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514698690?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 15:21","pubTimestamp":1740468100,"startTime":"0","endTime":"0","summary":"2025.02.25本文字数：995，阅读时长大约3分钟导读：HOOKIPA Pharma因研发管线受挫、罗氏终止合作及投资机构信心不足，曾计划收购Poolbeg Pharma以拓展业务，但近期因资金状况改善而终止收购。然而，鉴于CAR-T市场增长放缓及Poolbeg核心产品POLB 001市场前景存疑，收购的必要性受到质疑。然而，最近HOOKIPA Pharma宣布终止收购计划。在这种背景下，即便HOOKIPA Pharma完成了对Poolbeg Pharma的收购，吉利德也未必会将Poolbeg的POLB 001纳入其开发计划。从这个角度来说，收购Poolbeg Pharma可能并不是一个明智的选择。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225175634abdc338d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225175634abdc338d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4022","IE00B19Z3581.USD","LU0234570918.USD","LU1585245621.USD","GILD","LU1839511570.USD","IE00B3T34201.USD","LU2087621335.USD","LU0289739699.SGD","LU1430594728.SGD","LU2089984988.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","IE0002270589.USD","BK4139","CAR","BK4588","BK4230","LU2468319806.SGD","BK4583","IE00B7SZLL34.SGD","LU0320765992.SGD","LU1066051498.USD","IE00BSNM7G36.USD","LU1066053197.SGD","BK4585","BK4550","BK4532","IE00B19Z3B42.SGD","LU1571399168.USD","BK4568","IE00BKVL7J92.USD","LU0889565916.HKD","BK4566","BK4578","LU0109394709.USD"],"gpt_icon":0},{"id":"2514304620","title":"吉利德(GILD.US)突破性长效HIV疗法在欧洲获得加速审评","url":"https://stock-news.laohu8.com/highlight/detail?id=2514304620","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514304620?lang=zh_cn&edition=fundamental","pubTime":"2025-02-25 14:30","pubTimestamp":1740465038,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，吉利德科学公司今日宣布，欧洲药品管理局接受该公司为lenacapavir递交的上市许可申请，每半年注射一次，作为HIV感染的暴露前预防疗法。EMA人用药品委员会认为，每半年一次用于预防HIV感染的lenacapavir在公共卫生和治疗创新方面具有重大意义，上市申请将按加速审评时间表进行评估。在PURPOSE 2中，lenacapavir治疗组中99.9%的受试者未感染HIV，与背景HIV感染率相比，感染风险降低96%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1253915.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IE00BSNM7G36.USD","LU1430594728.SGD","LU2468319806.SGD","IE00B3T34201.USD","BK4585","BK4566","BK4583","LU0889565916.HKD","BK4588","LU1571399168.USD","BK4139","BK4532","BK4568","LU0234570918.USD","LU2087621335.USD","GILD","IE00BKVL7J92.USD","LU0109394709.USD","IE00BZ1G4Q59.USD","LU1066053197.SGD","IE00B19Z3581.USD","BK4578","LU1585245621.USD","LU1839511570.USD","LU0289739699.SGD","LU2089984988.USD","IE0002270589.USD","LU0320765992.SGD","LU0058720904.USD","BK4550","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU1066051498.USD"],"gpt_icon":0}],"pageSize":16,"totalPage":2,"pageCount":1,"totalSize":30}]}}